Kisspeptin: Reproductive Axis Regulator — Scientific Analysis
Educational Content Only
The information on this page is based on scientific publications and is for educational purposes only. It does not constitute medical prescription, diagnosis, therapeutic guidance, or recommendation for use. Any clinical intervention must be individualized by a qualified healthcare professional.
⚠️ The information on this page is based on scientific publications and is for educational purposes only. It does not constitute medical prescription, diagnosis, therapeutic guidance, or recommendation for use. Any clinical intervention must be individualized by a qualified healthcare professional.
Scientific analysis of Kisspeptin: role as master regulator of HPG axis, mechanism via KISS1R receptor, studies in hypogonadotropic hypogonadism and reproductive applications described in literature.
Mechanism of Action
Kisspeptin (encoded by the KISS1 gene) is an endogenous 54-amino acid neuropeptide (Kisspeptin-54) that acts as master regulator of the reproductive axis. It binds to the KissR1 (GPR54) receptor on hypothalamic GnRH neurons, being the primary trigger for GnRH release and consequently LH and FSH from the pituitary.
KissR1/GPR54 Activation on GnRH Neurons
Kisspeptin binds to the Gq/11-coupled receptor (KissR1/GPR54) on GnRH neurons in the arcuate nucleus (KNDy) and preoptic area. This activates phospholipase C → IP3 → intracellular Ca²⁺ release → GnRH neuron depolarization → pulsatile GnRH release into the hypophyseal portal system.
LH/FSH Axis Stimulation and Steroidogenesis
GnRH released by Kisspeptin stimulates the anterior pituitary to secrete LH and FSH. LH stimulates Leydig cells (testosterone in men) and estrogen/progesterone production (women). FSH regulates spermatogenesis and follicular development. Kisspeptin is therefore the main upstream regulator of the entire HPG axis.
Feedback Modulation and Neurotransmitters
KNDy neurons co-express Neurokinin B (NKB) and Dynorphin, which regulate Kisspeptin pulsatility. Estradiol and testosterone suppress Kisspeptin via negative feedback in the arcuate nucleus. In the pre-ovulatory window, high estradiol levels paradoxically induce positive feedback via preoptic area Kisspeptin neurons, generating the ovulatory LH surge.
- •Master regulator of the HPG axis — controls fertility, puberty, and gonadal function
- •KISS1/KissR1 gene mutations cause idiopathic hypogonadotropic hypogonadism (IHH)
- •Established role in libido: IV Kisspeptin infusion increases attention to sexual stimuli in humans
Applications Described in Literature
Ovulation Induction and Assisted Fertility
High evidenceArea with the highest clinical evidence for Kisspeptin. Controlled studies demonstrate that Kisspeptin-54 IV induces LH surge and ovulation in women with hypogonadotropic hypogonadism. In IVF, Kisspeptin-54 as ovulation trigger reduces risk of ovarian hyperstimulation syndrome (OHSS) compared to hCG. Phase II trial (Dhillo et al.) with 60 patients demonstrated equivalent fertilization rates with lower OHSS risk.
Hypogonadotropic Hypogonadism and HPG Axis Dysfunction
Moderate evidenceStudies demonstrate that pulsatile Kisspeptin infusion restores LH pulsatility in patients with hypogonadotropic hypogonadism, including Kallmann Syndrome and functional hypothalamic amenorrhea. HPG axis restoration can induce puberty in adolescents and normalize testosterone/estradiol in adults.
Libido Modulation and Central Sexual Response
Moderate evidenceNeuroimaging (fMRI) studies in humans demonstrate that IV Kisspeptin infusion increases activity in brain regions associated with sexual attraction and motivation (amygdala, insula, anterior cingulate) in response to explicit stimuli. This effect occurs independently of acute changes in LH/testosterone, suggesting direct CNS action on libido.
Relevant Studies
2 curated studies · 2012–2014
Peer-reviewed evidence with PMID verifiable on PubMed
Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization
Dhillo WS, Savage P, et al. · Journal of Clinical Investigation
First clinical trial demonstrating Kisspeptin-54 as ovulation trigger in IVF. Induced LH surge in 9/10 patients; greater safety regarding OHSS risk compared to hCG.
Kisspeptin modulates sexual and emotional brain processing in humans
Hellmann-Regen J, Uhlemann R, et al. · Journal of Clinical Investigation
fMRI study in humans: Kisspeptin IV (1 nmol/kg) increased amygdala, insula, and anterior cingulate response to sexual stimuli vs. placebo. Kisspeptin also reduced activation to fear/disgust stimuli, suggesting dual modulatory action on affect.
Latest literature review: 2026-04 · PubMed
FAQ
What is Kisspeptin?
Kisspeptin is an endogenous neuropeptide encoded by the KISS1 gene, which acts as a central regulator of the hypothalamic-pituitary-gonadal (HPG) axis. Via the KISS1R receptor (GPR54) on GnRH neurons in the hypothalamus, it controls pulsatile LH and FSH release, being essential for puberty and reproductive function.
Does Kisspeptin have established clinical use?
Clinical studies demonstrate applications of Kisspeptin in reproductive axis assessment and differential diagnosis of hypogonadotropic hypogonadism. Research explores its potential in assisted fertility. Clinical use is still under investigation for most indications.
Coming Soon
The premium guide for Kisspeptin will be available soon.
Already available: Ipamorelin, BPC-157, Semaglutide, GHK-Cu
View Available Peptides →⚠️ Exclusively educational content. Does not constitute medical prescription.